Accounting standard newly cited
Filing comparison
FENNEC PHARMACEUTICALS INC. cited accounting standard ASU 2023-09 for the first time in this filing series
The Company adopted ASU 2023-09 on January 1, 2025, on a prospective basis, and the adoption affected only the Company’s income tax disclosures and did not have an impact on its consolidated results of operations, financial position or cash flows.
Evidence
- Adopted
- 2023-09
- Adoption year stated
- 2025
- Contexts
- The Company adopted ASU 2023-09 on January 1, 2025, on a prospective basis, and the adoption affected only the Company’s income tax disclosures and did not have an impact on its consolidated results of operations, financial position or cash flows.
- New standards
- 2023-09, 2025-05
- Prior filed
- 2025-03-26
- Prior form
- 10-K
- Restates existing policy
- No
- Source
- accounting standards update (ASU) reference comparison
- Why
- An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.